This independent satellite symposium will provide clinicians with updated information on clinical practice guidelines, practical therapeutic applications of targeted agents, and ongoing research to expand the treatment armamentarium for the treatment of patients with hepatocellular carcinoma.
Presented for attendees of the 59th AASLD Annual Meeting. This is not an official function/event of the American Association for the Study of Liver Diseases.
Program Director
Jordi Bruix, MD
Associate Professor of Medicine
University of Barcelona
Head, Barcelona Clinic-Liver Cancer Group
Liver Unit
Hospital ClĂnico of Barcelona
Barcelona, Spain
Faculty
Adrian M. Di Bisceglie, MD, FACP
Professor of Internal Medicine
Chairman
Department of Internal Medicine
Saint Louis University School of Medicine
Chief, Hepatology
Division of Gastroenterology and Hepatology
Saint Louis University Hospital
St Louis, Missouri
Riccardo Lencioni, MD
Alan P. Venook, MD
Professor of Clinical Medicine
Department of Hematology and Oncology
Division of Medical Oncology
University of California, San Francisco
San Francisco, California